- Rise in cellular assay demand for drug discovery screening procedures is driving the in-vitro toxicology testing market
- North America is witnessing substantial market growth due to rise in focus on drug discovery in the U.S. and Canada
WILMINGTOM, Del., Dec. 6, 2022 /PRNewswire/ -- According to a market report published by Transparency Market Research, the global in-vitro toxicology testing market was valued at US$ 27 Bn in 2021.
The past few years have witnessed increasing number of new diseases, which has put the focus on developing new drugs to help cure patients suffering from these diseases. The demand for toxicology testing methods such as in-vitro toxicology testing has risen in a bid to ensure the end product is free of any toxic content.
Application areas that use in-vitro toxicology testing market include systemic toxicology, cardiotoxicity, ocular toxicity, and dermal toxicity. Leading players in the in-vitro toxicology testing market are collaborating with smaller players in order to expand presence in the global market and increase revenue.
Get Exclusive PDF Sample Copy of In-vitro Toxicology Testing Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=73510
Key Findings of In-vitro Toxicology Testing Market Study
Rise in Cellular Assay Demand in Drug Discovery Screening Procedures Boosting Market Growth: Based on method, the global in-vitro toxicology testing market can be classified into cellular assay, biochemical assay, ex-vivo, and in-silico. Cellular assay emerged as the dominant segment in 2021. This is ascribed to increasing cellular assay deployment in drug discovery screening procedures to identify cytotoxicity. Furthermore, cellular assays have been used in the initial stages of drug development by leading players in the pharmaceutical industry, which has triggered the growth of the cellular assay segment.
In-vitro Toxicology Testing Market - Key Drivers
- Increase in the number of pharma companies focusing on R&D activities due to surge in competition in the healthcare industry is one of the key factors driving the global in-vitro toxicology testing market
- Improvements to existing in-vitro toxicology tests to examine medicines' influence on cells and tissues are expected to fuel market expansion during the forecast period
- Rise in demand for ex-vivo toxicology testing as it permits drug screening tests to be conducted in sterile and dynamic environment is likely to augment the in-vitro toxicology testing market between 2022 and 2032
- Government initiatives and measures such as offering finances to leading players for research activities and providing favorable reimbursement policies is expected to help industry growth during the forecast timeline
Ask for References - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=73510
In-vitro Toxicology Testing Market - Regional Market Insights
North America is a highly attractive region for in-vitro toxicology testing owing to factors such as increase in focus on drug discovery by governments and introduction of biosimilar drugs in countries such as the U.S. Furthermore, stringent standards for medicine development in the U.S. have led to increase in deployment of in-vitro toxicology testing and helped in business growth.
In-vitro Toxicology Testing Market - Key Players
The global in-vitro toxicology testing market is competitive due to the presence of several prominent players. Entry of new players during the forecast period is likely to intensify competition in the market.
Leading players strive to establish research centers in countries offering key resources such as land and labor at affordable prices for in-vitro toxicology testing procedures. For instance, in September 2019, Covance announced the launch of new research and development center in China in a bid to bolster its in-vitro toxicology testing business in Asia Pacific.
Well-established players in the global market include GE Healthcare, Abbott, Thermo Fischer Scientific, Agilent Technologies, and Merck KGaA.
The global market is segmented as follows:
- By Method
- Cellular Assay
- Live Cells
- Fixed Cells
- Biochemical Assay
- In-Silico
- Ex-vivo
- By End-use
- Pharmaceutical Industry
- Cosmetics & Household Products
- Academic Institutes and Research Laboratories
- Diagnostics
- Chemical Industry
- Food Industry
- By Technology
- Cell Culture Technology
- High Throughput Technology
- Molecular Imaging
- OMICS Technology
- By Application
- Systemic Toxicology
- Dermal Toxicity
- Endocrine Disruption
- Ocular Toxicity
- Others
- By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=73510
Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:
Hysteroscopy Procedures Market: Hysteroscopy procedures market is anticipated to reach more than US$ 9 Bn by the end of 2032 and to grow at a CAGR of 8.4% from 2022 to 2032.
Medical Device Analytical Testing Outsourcing Market: Medical Device Analytical Testing Outsourcing Market is anticipated to reach more than US$ 16.7 Bn by the end of 2032 and to grow at a CAGR of 11.2% from 2022 to 2031.
Cold Plasma Market: Cold plasma market is anticipated to reach more than US$ 17.3 Bn by the end of 2032 and to grow at a CAGR of 18.6% from 2022 to 2032.
Mesenchymal Stem Cells Market: Mesenchymal Stem Cells Market is anticipated to reach more than US$ 16.4 Bn by the end of 2031 and to grow at a CAGR of 17.3% from 2022 to 2031.
Operating Room Integration Market: Operating Room Integration Market is anticipated to reach more than US$ 7.2 Bn by the end of 2031 and to grow at a CAGR of 13.9% from 2022 to 2032.
Near Infrared Imaging Market: Near Infrared Imaging Market is anticipated to reach more than US$ 785.1 Mn by the end of 2032 and to grow at a CAGR of 12.7% from 2022 to 2032.
Viral Vector Production Market: Viral vector creation market is worth more than US$ 1.3 Bn by 2032 and it is estimated to expand at a CAGR of 28.3% from 2022 to 2032.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/in-vitro-toxicology-testing-market-projected-to-grow-at-cagr-of-13-between-2022-and-2032-tmr-study-301695670.html
